The Ozempic conversation has been everywhere for two years now. What has been almost entirely missing from it is how these medications interact with the hormonal shifts already happening in a woman's body after 45.
That is the piece almost nobody explains properly. And it is the piece that matters most in perimenopause.
GLP-1 is a hormone your gut already makes. Semaglutide and similar medications mimic it at much higher doses than your body produces on its own.
GLP-1 receptors sit in your pancreas, your brain, your stomach, and your ovaries. This is not a single-purpose drug acting on a single system.
In perimenopause, your estrogen is fluctuating unpredictably and your insulin sensitivity is already declining. Cortisol patterns are shifting too, which is part of why sleep and belly fat feel different than they used to.
GLP-1 medications improve insulin sensitivity and lower blood sugar, which is genuinely useful for a body that is becoming more insulin resistant with age. Ring a bell? That is why some women feel steadier energy and fewer cravings within weeks.
A 2023 review in Nature Reviews Endocrinology examined how GLP-1 signaling interacts with the female reproductive axis. Estrogen appears to enhance GLP-1 sensitivity, and GLP-1 in turn influences the hypothalamic signals that regulate reproductive hormones.
In practical terms, this means your response to the medication may shift as your estrogen shifts. Women in late perimenopause sometimes report different appetite effects than they had a year earlier, and the research suggests this is biologically plausible.
There is also early evidence, from smaller studies on PCOS and metabolic syndrome, that GLP-1 medications can affect menstrual cycle patterns and androgen levels. The data in perimenopausal women specifically is still thin.
"I was so tired of leaking every time I laughed, sneezed, or just stood up too fast. I felt like I had tried everything, but I have to say, this actually works way better than Kegels! It's just a simple 7-second 'left-and-right' movement that you do right on the toilet. There are no pills to take and you don't need any weird equipment. It's just a small, natural move that completely strengthened my bladder and pelvic floor. If you're over 40 and struggling with this too, you really have to watch this short video and see it for yourself!"
Rapid weight loss itself changes hormones. Fat tissue produces estrogen, so losing a significant amount quickly can lower circulating estrogen further in a body that is already running low.
For some women this shows up as worsening hot flashes, drier skin, or a sudden dip in libido within the first few months. Ever notice that the "side effects" list rarely mentions any of this?
Your body is not misbehaving on the medication. It is responding to a hormonal signal at a stage of life when the whole hormonal system is already recalibrating.
That does not mean GLP-1s are wrong for perimenopausal women. It means the decision deserves more depth than "here is the prescription, watch for nausea."
If you are considering one, three questions are worth raising with your doctor. Ask whether baseline labs, including fasting insulin, thyroid, and a lipid panel, make sense before starting.
Ask how the medication might interact with HRT if you are on it or considering it. Ask what the plan is for monitoring bone density and lean mass, since both are already vulnerable in this decade.
None of these questions will offend a good clinician. They are the questions a woman navigating perimenopause should be asking about any intervention that touches her hormones.
You will not get every decision about your body exactly right. Nobody does.